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Exposure of perfused livers of fed rats to 60 mM K’ induces rapid responses in the Caz”-sensitive metabolic 
events, gly~og~nolysis, cytoplasmie and mit~hondria~ NA~~~NAD ratios and octanoate oxidation. All 
increase within 45 s of Kc addition. Metabolic responses were not observed following K+ addition to livers 
perfused in the absence of added Ca 2+ Movements of Ca*+ into the liver were suggested from experiments 
in which 45Ca2+ uptake was measured. The Caz+ antagonists verapamil, diltiazem and Niz’ essentially abol- 
ished changes to tissue metabolism and Caz+ fluxes induced by K+ addition. K+-induced changes were con- 
sistent with Ca*+ channel activiation. 
Liver Potassium depolarization 
1. INTRODUCTION 
Calcium channels in the plasma membrane play 
a crucial role in a number of different tissues by 
coupling membrane xcitation to cellular responses 
such as hormone secretion, neurotransmitter 
release and muscle contraction (review [l}). While 
the activation of Ca2’ channels by membrane 
depolarization in tissues like smooth and cardiac 
muscles and brain has been known for a number of 
years, many important details remain to be 
established [1,2]. 
Although the possible operation of such Ca2’ 
channels in liver tissue has not been extensively in- 
vestigated, in recent reports it has been suggested 
that Ca2+ channels or pores may play a role in the 
elevation of cytoplasmic Ca’+ concentrations in 
perfused rat liver and hepatocytes in response to 
the action of adrenergic agonists [3,4]. These com- 
pounds are known to stimulate unidirectional Ca” 
influx in rat hepatocytes [4-7] and in perfused rat 
liver I3). 
One approach to the study of Ca’+ channels has 
relied on the ability of pharmacological agents 
known as Ca2+ antagonists to inhibit selectively 
Glycogenol_vsis Calcium antagonist 
Ca” channel operation [2,8]. In this regard a re- 
cent study which examined Ca” antagonist bind- 
ing in a range of tissues indicated that CaZf chan- 
nels may also be present in liver 121. 
Here we have examined the effect of depolariz- 
ing concentrations of K+ on aspects of 
Ca2’-sensitive metabolism in perfused rat liver. 
The results described are consistent with the notion 
that Ca’+ channels are present in the liver plasma 
membrane. 
2. EXPERIMENTAL 
Wistar-strain albino rats (200-280 g body wt) 
having free access to food were anaesthetized with 
sodium pentobarbitone (50 mg/kg). Livers were 
perfused with Krebs-Henseleit [9] bicarbonate 
medium equilibrated with &,/CO2 (19: I) in a 
flow-through mode as in IlO]. The perfusion 
medium was modified to contain 1.3 mM CaCll 
and a proportion of the final NaCl content 
(55 mM NaCl) was administered to the perfusate 
by an infusion syringe containing 4 M NaCl. Dur- 
ing the perfusion the perfusate KC1 concentration 
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could be increased from 5 to 60 mM by replacing 
the NaCl infusion syringe with an identical syringe 
of 4 M KCl. In this manner the perfusate K+ con- 
centrations were routinely maintained at 60 mM 
from 16 min of perfusion till the conclusion of the 
experiment. When Ca2+ was omitted from the per- 
fusion medium the Ca2+ concentration was re- 
duced to approx. 5pM as revealed by atomic 
absorption spectroscopy. 
2.2. Analytical procedures 
Perfusate oxygen concentrations were con- 
tinuously monitored with a Clark-type oxygen 
electrode as detailed [lo]. Effluent perfusate was 
assayed for glucose by the glucose oxidase/perox- 
idase method as described [l 11. Perfusate lactate, 
pyruvate and ketone bodies as well as production 
of 14C02 from [l-14C]octanoate was estimated as 
in [12]. Loss of Ca2+ from the perfusate was deter- 
mined as described [3]. Lag times for oxygen 
responses and metabolite outputs (glucose, lactate, 
pyruvate, ,&hydroxybutyrate, acetoacetate and 
4’Ca2+ were determined as in [12] and the time 
courses of the responses corrected accordingly. 
2.3. Chemicals and materials 
The glucose assay kit (510-A) and nifedipine 
were obtained from Sigma, St Louis, MO. Lactate 
dehydrogenase and &hydroxybutyrate dehydro- 
genase were from Boehringer, Mannheim. Hy- 
amine hydroxide and [I-‘4C]octanoate were sup- 
plied by New England Nuclear, Boston, MA. 
Verapamil was from Knoll, Munich, and diltiazem 
was a kind gift from Professor D. Marme, 
Goedecke Research Institute, Freiburg, FRG. All 
other chemicals were of analytical grade. 
3. RESULTS 
3.1. Effect of K+ on various metabotrc responses 
in the perfused rat liver 
The effects of increasing the perfusate K+ con- 
centration from 4 to 60 mM on a number of 
metabolic responses, previously shown to be 
stimulated following the administration of 
Ca2+-mobilizing hormones to the perfused rat liver 
[lo, 121, are shown in fig. 1. Increased glucose out- 
put (fig. la) is evident between 30 and 40 s after K+ 
addition. Maximal increases of approx. 150% are 
observed by 75 s. A sharp decline in glucose output 
follows to reach values only 35% above basal 
levels by 90-100 s. A further increase in glucose 
output is then observed which continues from 2 to 
6 min of K+ infusion, when the experiments were 
terminated. 
Omission of Ca2+ from the perfusate completely 
prevents K+-induced changes in glucose output. In 
addition the figure shows that maximally effective 
doses of the Ca2+ antagonists verapamil (4pM), 
diltiazem (50 PM) and Ni2+ (1.3 mM) almost com- 
pletely prevent K+-induced changes in glucose out- 
put. Half-maximal inhibition by verapamil, 
diltiazem and Ni2+ was observed at approx. 0.5, 10 
and 250 ,uM, respectively. In contrast, nifedipine, 
a potent Ca2+ antagonist in other tissues [2,8], had 
no effect on Kf-induced effects in the perfused 
liver when used at up to 2 PM (not shown). 
As detailed in section 2, whenever perfusate K+ 
concentrations were elevated to 60 mM, a cor- 
responding decrease in Na+ concentration was 
achieved. Changes in Na+ concentration, however, 
did not appear to be involved in the metabolic ef- 
fects described, since in control experiments where 
Na+ was replaced by choline, no significant 
metabolic effects were observed. 
Additionally, co-infusion of the ai-adrenergic 
antagonist, prazosin, failed to influence the 
K+-induced changes in glucose output observed in 
fig. 1. 
The effect of raising the external K+ concentra- 
tion to 60 mM on perfusate [lactate]/[pyruvate] 
and p-hydroxybutyrate]/[acetoacetate] ratios, in- 
dicators of liver cytoplasmic and mitochondrial 
[NADH]/[NAD] ratios, respectively [13], are 
shown in fig.lb and c. Increases in the [lactate]/ 
[pyruvate] and p-hydroxybutyrate]/[acetoacetate] 
ratios were evident 30-40 and 70-75 s after K+ 
addition, respectively. Whereas the enhanced [lac- 
tate]/[pyruvate] ratio rapidly decreased after 45 s, 
the increased p-hydroxybutyrate]/[acetoacetate] 
ratio remained maximally stimulated from 2 min 
onwards. Similar to responses in glucose output, 
these K+-induced effects were almost totally 
abolished by pretreatment of livers for 5 min with 
either 4pM verapamil or 50pM diltiazem. Like- 
wise, K+-induced effects were not observed if Ca2+ 
was omitted from the perfusion medium (not 
shown). 
The rate of oxidation of tracer amounts of 
[l-‘4C]octanoate to 14C02 has previously been 
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Fig.1. Effect of verapamil, diltiazem, Ni2+ and Ca2+ on K+-induced changes to metabolic responses. Livers were 
perfused as described in section 2. The perfusate was sampled at the times indicated for glucose (A), for lactate and 
pyruvate (B), for&hydroxybutyrate and acetoacetate (C), or for [l-14C]octanoate oxidation to 14C02 (D). After 12 min 
of perfusion verapamil (4 /tM, w), diltiazem (50rM, A) or Ni2+ (1.3 mM, 0) was continuously infused where 
indicated. The perfusate K+ concentration was increased to 60 mM at 16 min (arrowed). In experiments where no added 
Ca*+ was present (A), livers were initially perfused for 10 min with buffer containing 1.3 mM Ca2+ and thereafter 
without added Ca’+. In some experiments prazosin (2 PM) was infused at 12 min and exhibited K+-induced responses 
identical to the control (0). In panel A data shown are the means + SE of 8 experiments where K+ alone was 
administered (0) and the means of 5 separate experiments for all other additions. For clarity the SE values (all of 
which were less than + 10%) have been omitted in these latter experiments. In panels B and C, data shown are the 
means + SE for 4 separate xperiments in the absence (e) and 3 separate xperiments in the presence of verapamil or 
diltiazem. In panel D livers were continuously infused with [l-14C]octanoate (25.1 pCi/mol) to a final concentration 
of 0.2pM. Samples of perfusate were assayed for 14C02 as described in section 2. Data shown are the means + SE 
of 4 separate experiments in the absence (0) and 3 separate experiments in the presence of verapamil or diltiazem. 
used to monitor tricarboxylic acid cycle flux in the 
perfused rat liver [12,14]. As shown in fig.la, an 
increase in octanoate oxidation was evident 60 s 
after K+ addition and maximal rates were observed 
by 90 s; thereafter the effect slowly declined. This 
K+-induced effect was also abolished by pretreat- 
ment with verapamil or diltiazem or by the omis- 
sion of Ca2+ from the perfusate (not shown). 
3.2. Evidence that increasing the perfusate K+ 
concentration promotes CaZ’ inflow 
The change in Ca2+ -sensitive metabolism seen in 
fig.1 following K+ addition to the perfusion 
medium suggested that such action led to Ca2+ in- 
flux. This was tested directly with experiments 
employing 45Ca2+ [3], since the Ca2+-selectrode 
[lo] could not accurately monitor perfusate Ca2+ 
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concentration changes under these experimental 
conditions where K+ concentrations were varied 
widely. 
A tracer amount of ‘%a2 was continuously in- 
fused into the inflowing perfusion medium, from 
5 min before K+ addition. The 45Ca2+ content of 
the effluent perfusion medium reached a steady 
level within 2-3 min, which corresponded to the 
continuous uptake of approx. 1.8% of the inflow- 
ing 45Ca2+. The uptake of radioisotope apparently 
reflects the continuing exchange of extracellular 
4SCa2+ for 40Ca2+ in both extracellular and in- 
tracellular compartments 131. 
The effect of K+ addition on the uptake of 
45Caz+ from the perfusate is shown in fig.2. The 
effect is transient with an enhanced rate of uptake 
being observed some 20-30 s after K+ addition. 
Maximal effects occur by 40-50 s and thereafter 
decline to reach basal values by 2-3 min. These 
Ca2+ movements are almost completely abolished 
by pretreatment with the Ca2’ channel blocker 
verapamil (fig.2). 
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Fig.2. Effect of verapamil on K+-induced uptake of 
perfusate 45CaZ+. Livers of fed rats were perfused with 
Krebs-Henseleit buffer containing 1.3 mM Ca2+ as 
described in section 2. A tracer amount of 45Ca2+ (final 
spec. act. -50 nCi/ml) was continuously infused into 
the inflowing buffer after 11 min of perfusion. In some 
experiments verapamil (final concentration, 4 PM) was 
continuously infused after 12 min of perfusion. At 
16 min the perfusate KC concentration was increased to 
60 mM (arrowed) as detailed in section 2. Effluent 
samples were taken for determination of radioactivity. 
Data shown are the means t SE of 4 experiments in the 
absence (0) and 3 experiments in the presence of 
verapamil (m). 
4. DISCUSSION 
Our data show that a number of metabolic 
responses known to be enhanced by Ca2+- 
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mobilizing hormones in the perfused rat liver 
(review [15]) are similarly stimulated by a rapid in- 
crease in the perfusate K+ concentration. The 
K+-induced metabolic responses occurred in the 
presence of the cYi-adrenergic blocker prazosin, 
clearly suggesting the non-involvement of the 
al-receptor in any mobilization of the Ca” that 
may have resulted here. 
The conclusion that an increased inflow of Ca2+ 
into the perfused rat liver did take place in the pre- 
sent work consequent o the action of depolarizing 
concentrations of Kf is supported by the following 
observations. 
(i) Changes observed in perfusate 45Ca2” content 
were consistent with a transient stimulation of 
Ca*+ uptake by the tissue. (ii) All metabolic 
responses to K+ addition were obligatorily depen- 
dent on the presence of extracellular Ca2”. (iii) The 
responses were almost completely inhibited by the 
Ca*+ channel blockers verapamil, diltiazem and 
Ni’+ . The concentration of these agents required to 
inhibit the effects of Kf addition were in the range 
used to inhibit Ca2+ channels in other tissues and 
were well below the range where these agents may 
interact with calmodulin [16]. Thus the inhibitory 
effects of Ca*+ antagonists on metabolic responses 
were unlikely to result indirectly from an inhibition 
of calmodulin-sensitive steps in the various 
metabolic pathways. Further evidence suggesting 
enhanced Ca*+ influx was provided in experiments 
in which the metabolic effects of I(’ were ex- 
amined. These effects mimicked those induced by 
cu-adrenergic agonists and the Ca2+ ionophore 
A23187, agents previously shown to alter Ca2+ 
distribution in liver cells and to elevate cytoplasmic 
Ca2+ concentrations [17-201. Thus increases in 
glucose output in response to a-agonists, A23187 
and K’ addition may all arise from an enhanced 
cytoplasmic Ca2+ concentration and subsequent 
activation of phosphorylase kinase. Other similar 
metabolic effects induced by these agents may also 
result from an altered distribution of cellular Ca2+. 
The question arises as to whether the inflow of 
Ca*+ suggested by the above-mentioned observa- 
tions occurs via specific Ca2+ channels located in 
the plasma membrane. Certainly concentrations of 
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K’ ranging from 50 to 110 mM pr~vious~~ have 
been used to induce membrane depolarization and 
activation of Ca2+ channels in a number of dif- 
ferent tissue preparations [21-231. Although the 
operation of such channels in liver tissue has been 
suggested by previous workers 171, it is only recent- 
ly that more substantive vidence for their presence 
has appeared [3,4]. 
However, the present data also do not necessari- 
ly indicate the presence of voltage-dependent Cazf 
channels in rat liver. Whilst K+-induced effects 
were inhibited by agents which effectively block 
these channels in other tissues, the Ca2+ an- 
tagonists used may also inhibit receptor-operated 
Ca2’ channeis 1241 and may have other non- 
specific effects 1251. 
The Kf-induced metabolic responses described 
probably do not result from the operation of 
Ca2+-activated K+ channels since some evidence 
suggests that these channeis are not operative in rat 
liver [26,27] and apamin, an agent which inhibits 
Ca’+-activated K+ channels in other tissues did not 
affect the K-induced responses (not shown). 
Finally, work in the present paper has revealed 
a further useful means whereby the interplay of ex- 
tracellular and cytoplasmic Ca*+ and the ensuing 
induced physiological responses (review [15]>, can 
be explored in the intact perfused rat liver indepen- 
dent of cur-receptor occupancy. 
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